Search

Your search keyword '"Jevtovic, D"' showing total 170 results

Search Constraints

Start Over You searched for: Author "Jevtovic, D" Remove constraint Author: "Jevtovic, D"
170 results on '"Jevtovic, D"'

Search Results

51. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

52. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies

53. Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

54. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

55. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

56. Dialysis and renal transplantation in HIV-infected patients: a European survey

57. Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe

58. Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe

59. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

60. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

61. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

62. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

63. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

64. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

65. Health Worker Training in the Western Balkans: Report of the First Phase of Rapid Scale Up

66. CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use

67. Severe bacterial non-aids infections in HIV-positive persons:incidence rates and risk factors

68. CD4 count and viral load specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use

70. The role of passive immunization in hiv-positive patients : a case report.

76. Original Research Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy.

77. Are Specific Antiretrovirals associated with an Increased Risk of Discontinuation due to Toxicities or Patient/Physician Choice in patients with Hepatitis C Virus Coinfection?

78. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

79. Older age at the time of liver biopsy is the important risk factor for advanced fibrosis in patients with chronic hepatitis C

81. TERT single nucleotide polymorphism rs2736098 but not rs2736100 is associated with telomere length in HIV-infected patients on cART.

82. Association between Combination Antiretroviral Therapy and Telomere Length in People Living with Human Immunodeficiency Virus.

83. HIV-1 subtype B spread through cross-border clusters in the Balkans: a molecular analysis in view of incidence trends.

84. Chronic Kidney Disease and Nephrology Care in People Living with HIV in Central/Eastern Europe and Neighbouring Countries-Cross-Sectional Analysis from the ECEE Network.

85. Helicobacter pylori infection rates in dyspeptic Serbian HIV-infected patients compared to HIV-negative controls.

86. Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.

87. People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe - data from Euro-guidelines in Central and Eastern Europe Network.

88. Severe hepatotoxicity induced by efavirenz in a treatment-naïve, low body mass index HIV-infected, female patient with no hepatitis and other virus co-infections.

89. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort.

90. Analysis of variability of urinary excreted JC virus strains in patients infected with HIV and healthy donors.

91. Influenza A H1N1 virus infection among pregnant women in a tertiary hospital in Belgrade, Serbia.

92. HIV care in Central and Eastern Europe: How close are we to the target?

93. Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study.

94. Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study.

95. Correlation of Leptin, Adiponectin, and Resistin Levels in Different Types of Lipodystrophy in HIV/AIDS Patients.

96. Intravenous drug use - an independent predictor for HCV genotypes 3 and 4 infection among HIV/HCV co-infected patients.

97. Forensic application of phylogenetic analyses - Exploration of suspected HIV-1 transmission case.

98. High Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers among HIV-Infected Patients in Serbia.

99. Rubella immune status of neonates - a window towards seroprevalence among childbearing women.

100. Clinical characteristics of imported malaria: An 11-year experience in a Serbian referral center.

Catalog

Books, media, physical & digital resources